Free Trial

Ambu A/S (OTCMKTS:AMBBY) Shares Up 3.6% - Here's What Happened

Ambu A/S logo with Medical background

Shares of Ambu A/S (OTCMKTS:AMBBY - Get Free Report) shot up 3.6% on Monday . The stock traded as high as $16.89 and last traded at $16.89. 443 shares changed hands during mid-day trading, a decline of 5% from the average session volume of 467 shares. The stock had previously closed at $16.31.

Ambu A/S Stock Performance

The company has a market capitalization of $3.97 billion, a PE ratio of 99.35 and a beta of 1.45. The company has a 50 day moving average of $17.59 and a two-hundred day moving average of $17.14. The company has a debt-to-equity ratio of 0.08, a current ratio of 2.60 and a quick ratio of 1.47.

Ambu A/S (OTCMKTS:AMBBY - Get Free Report) last issued its quarterly earnings results on Thursday, January 30th. The company reported $0.10 earnings per share for the quarter. Ambu A/S had a return on equity of 5.67% and a net margin of 5.69%.

About Ambu A/S

(Get Free Report)

Ambu A/S develops, produces, and sells medical devices to hospitals, clinics, and rescue services worldwide. The company offers anaesthesia, and patient monitoring and diagnostics products. The company also offers endoscopy products, such as bronchoscopes, rhinolaryngoscopes, duodenoscopes, cystoscopes, and display units; and neurology products, including EEG and EMG electrodes, EMG guided injections, and intraoperative monitoring products.

Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Ambu A/S Right Now?

Before you consider Ambu A/S, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ambu A/S wasn't on the list.

While Ambu A/S currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

5 Stocks to BUY NOW in May 2025
3 Stocks Offering Rare Generational Buying Opportunities
Make Your Money Work Harder: The Power of Dividend Investing

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines